Sebastian Lotter

Jorge Torres Gómez, Pit Hofmann, Lisa Y. Debus et al.

Recent developments in the Internet of Bio-Nano-Things (IoBNT) are laying the foundation for innovative healthcare applications that envision a network of remotely coordinated nanodevices within the human body to monitor and actuate over potential diseases. However, interconnecting such nanodevices requires communication strategies that can cope with molecular communication (MC) channels, whose complex, stochastic, and dynamic behavior often makes accurate physical modeling infeasible. To explore the limits of nanodevice interconnectivity under these conditions, this survey focuses on data-driven communication strategies for MC systems, with particular emphasis on machine learning (ML) methods and neural network (NN) architectures for a robust and adaptive communication scheme at the nanoscale. Research on NN-enabled MC spans several aspects covered in this survey, including NNs for communication in IoBNT networks, the feasibility of biocompatible NN realization, explainable approaches, and the generation of training datasets. We also include open-source code examples to support reproducible research across key MC scenarios. Finally, we identify emerging challenges, including the need for robust NN architectures, biologically integrated NN modules, and scalable training strategies.

Timo Jakumeit, Lukas Brand, Josep M. Jornet et al.

Motivated by classical communications engineering, early works in molecular communication (MC) largely adopted established modeling and signal processing concepts from wireless electromagnetic communication systems. In the context of the human cardiovascular system (CVS), MC channel models evolved from simple unbounded and single-duct environments mimicking individual blood vessels to complex vessel network (VN) topologies, generally at the expense of analytical tractability. Up until now, this has largely prohibited rigorous communication-theoretic analysis of large-scale VNs. In this work, we leverage a recently established closed-form analytical channel model for VNs, named mixture of inverse Gaussians for hemodynamic transport (MIGHT), to conduct the first systematic communication-theoretic study of MC in complex, large-scale VNs. Based on MIGHT, we derive a Poisson channel noise model and unveil structural analogies between multipath wireless communications (MWC) and advective-diffusive MC in VNs. In particular, we establish classical MWC metrics, namely the root mean squared (RMS) delay spread, the mean excess delay, and the coherence bandwidth, for MC in VNs and derive closed-form expressions for the channel frequency response and power delay profile (PDP). Building on this characterization, we propose a VN-adapted, coherent decision-feedback (DF) detector and show how the derived multipath metrics can inform the choice of critical system parameters like the symbol duration, the sampling time, and the memory length. Additionally, we evaluate the detector's performance in different VNs exhibiting inter-symbol interference (ISI). Together, these contributions open the door to a systematic, MWC-inspired MC system design for large-scale VNs.

Sebastian Lotter, Elisabeth Mohr, Andrina Rutsch et al.

Synthetic molecular communication (SMC) is a key enabler for future healthcare systems in which Internet of Bio-Nano-Things (IoBNT) devices facilitate the continuous monitoring of a patient's biochemical signals. To close the loop between sensing and actuation, both the detection and the generation of in-body molecular communication (MC) signals is key. However, generating signals inside the human body, e.g., via synthetic nanodevices, poses a challenge in SMC, due to technological obstacles as well as legal, safety, and ethical issues. Hence, this paper considers an SMC system in which signals are generated indirectly via the modulation of a natural in-body MC system, namely the gut-brain axis (GBA). Therapeutic GBA modulation is already established as treatment for neurological diseases, e.g., drug refractory epilepsy (DRE), and performed via the administration of nutritional supplements or specific diets. However, the molecular signaling pathways that mediate the effect of such treatments are mostly unknown. Consequently, existing treatments are standardized or designed heuristically and able to help only some patients while failing to help others. In this paper, we propose to leverage personal health data, e.g., gathered by in-body IoBNT devices, to design more versatile and robust GBA modulation-based treatments as compared to the existing ones. To show the feasibility of our approach, we define a catalog of theoretical requirements for therapeutic GBA modulation. Then, we propose a machine learning model to verify these requirements for practical scenarios when only limited data on the GBA modulation exists. By evaluating the proposed model on several datasets, we confirm its excellent accuracy in identifying different modulators of the GBA. Finally, we utilize the proposed model to identify specific modulatory pathways that play an important role for therapeutic GBA modulation.